Investigación / Grupos de investigación

Grupo  27

Farmacia Hospitalaria y Farmacogenómica

Publicaciones (412)

  • Taladriz-Sender, I; Hernández-Osio, G; Zapata-Cobo, P; Salvador-Martín, S; García-González, X; Balas, A; Sanjurjo-Sáez, M; López-Fernández, LA.

    An Inexpensive and Quick Method for Genotyping of HLA Variants Included in the Spanish Pharmacogenomic Portfolio of National Health System

    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2024; 25(20): [doi:10.3390/ijms252011207]

  • Puig, T; Leache, L; González-Senac, NM; Carreras, E; Gutiérrez-Valencia, M; Losa, L; Revuelta-Herrero, JL; Marrero-Alvarez, P; de Miguel, M; Arredondo, AA; Aranguren, A; Vilariño, A; Ruiz, VE; Fernández, I; Bilbao, J; González-Guerrero, C; del Pino, B; Garin, N.

    Prevalence of potentially inappropriate medications and prescription dynamics in elderly hospitalized patients in Spain

    BMC GERIATRICS. 2024; 24(1): [doi:10.1186/s12877-024-05308-3]

  • Lobo-Rodrígueza, C; Díaz-Redondoc, A; Chamorro-de-Vega, E; Ais-Larisgoiti, A; Ibares-Frias, L; Baniandrés-Rodríguez, O; Menchén, L; González-Fernández, CM.

    Experience of patients with immune-mediated inflammatory diseases seen in a multidisciplinary integrated care unit

    Journal Of Healthcare Quality Research. 2024; 39(5): 283-290 [doi:10.1016/j.jhqr.2024.04.006]

  • Collado-Borell, R; Gomis-Pastor, M; Rodríguez-Cabezas, M; Parro-Martín, A; Linares-Alarcón, A; Gutiérrez, E; González-Corominas, E; Fernández-Polo, A; Domínguez-Cantero, M; Arrondo-Velasco, A; Morillo-Verdugo, R.

    Guide for the efficient and safe delivery of Telepharmacy

    Health Policy and Technology. 2024; 13(4): Nº de citas: 1 [doi:10.1016/j.hlpt.2024.100899]

  • Badia, X; Calleja, MA; Escudero-Vilaplana, V; Pérez-Martínez, A; Piñana, JL; Poveda, JL; Vallés, JA.

    The value of the reflective discussion in decision-making using multi-criteria decision analysis (MCDA): an example of determining the value contribution of tabelecleucel for the treatment of the Epstein Barr virus-positive post-transplant lymphoproliferative disease (EBV+ PTLD)

    ORPHANET JOURNAL OF RARE DISEASES. 2024; 19(1): [doi:10.1186/s13023-024-03324-5]

  • Amor-García, MA; Chamorro-de-Vega, E; Rodríguez-González, CG; Iglesias-Peinado, I; Moreno-Díaz, R.

    Effects of a Pharmacist-Designed Clinical Decision Support System on Antimicrobial Stewardship

    Applied Clinical Informatics. 2024; 15(04): 679-688 Nº de citas: 1 [doi:10.1055/a-2341-8823]

  • Somoza-Fernández, B; Escudero-Vilaplana, V; Collado-Borrell, R; Perez-Ramírez, S; Villanueva-Bueno, C; Montero-Antón, MD; Herranz-Alonso, A; Sanjurjo-Saez, M.

    Severe neutropenia probably caused by enzalutamide and abiraterone in a prostate cancer patient

    JOURNAL OF ONCOLOGY PHARMACY PRACTICE. 2024; 30(7): 1268-1273 [doi:10.1177/10781552241264530]

  • Costas, DG; Ribed, A; Gimenez-Manzorro, A; Garutti, I; Sanz, FJ; Taladriz-Sender, I; Herrero, S; Rioja, Y; Carrillo, A; Herranz, A; Sanjurjo-Saez, M.

    Cost-effectiveness of preoperative pharmaceutical care consultations: a 5-year analysis

    EUROPEAN JOURNAL OF HOSPITAL PHARMACY. 2024; 32(3): 220-225 [doi:10.1136/ejhpharm-2024-004222]

  • Escudero-Vilaplana V; Guisado-Gil AB; Santos-Ramos B; Herranz A.

    Development and consensus of a dashboard model to evaluate research activity in Spanish Hospital Pharmacy Services.

    FARMACIA HOSPITALARIA. 2024; 48 Suppl 1: [doi:10.1016/j.farma.2023.12.007]

  • Escudero-Vilaplana, V; Guisado-Gil, AB; Santos-Ramos, B; Herranz, A.

    Development and consensus of a dashboard model to evaluate research activity in Spanish Hospital Pharmacy Services

    FARMACIA HOSPITALARIA. 2024; 48: 28-34 [doi:10.1016/j.farma.2024.03.006]

  • Gómez-Costas D; Romero-Jiménez RM; Lobato-Matilla ME; Culebras R; González JA; Herrero-Bermejo S; Herranz-Alonso AM; Sanjurjo-Saez M.

    Detection and reduction of errors in parenteral nutrition compounding through gravimetric and product control.

    FARMACIA HOSPITALARIA. 2024; 48(3): 116-121 [doi:10.1016/j.farma.2023.11.007]

  • de Lorenzo-Pinto, A; Redondo-Galán, C; García-González, X; Fernández-Alvarez, C; Andueza-Lillo, J; Sanjurjo-Sáez, M.

    Presence of metallic components in transdermal drug delivery systems and risk of skin burns

    FARMACIA HOSPITALARIA. 2024; 48(3): 129-132 [doi:10.1016/j.farma.2024.02.010]

  • Gómez-Costas, D; Romero-Jiménez, RM; Lobato-Matilla, ME; Culebras, R; González, JA; Herrero-Bermejo, S; Herranz-Alonso, AM; Sanjurjo, M.

    Detection and reduction of errors in parenteral nutrition compounding through gravimetric and product control

    FARMACIA HOSPITALARIA. 2024; 48(3): 116-121 [doi:10.1016/j.farma.2024.02.014]

  • de Lorenzo-Pinto A; Redondo-Galán C; García-González X; Fernández-Álvarez C; Andueza-Lillo J; Sanjurjo-Sáez M.

    Presence of metallic components in transdermal drug delivery systems and risk of skin burns.

    FARMACIA HOSPITALARIA. 2024; 48(3): 129-132 [doi:10.1016/j.farma.2023.11.003]

  • Salvador-Martín S; Rubbini G; Vellosillo P; Zapata-Cobo P; Velasco M; Palomino LM; Clemente S; Segarra O; Moreno-Álvarez A; Fernández-Lorenzo A; Pérez-Moneo B; Montraveta M; Sánchez C; Tolín M; Loverdos I; Fobelo MJ; Navas-López VM; Magallares L; García-Romero R; Torres-Peral R; Rodríguez A; Bossacoma F; Merino-Bohórquez V; Salcedo E; Álvarez R; Dopazo A; Sanjurjo-Sáez M; López-Fernández LA.

    Blood gene expression biomarkers of response to anti-TNF drugs in pediatric inflammatory bowel diseases before initiation of treatment.

    BIOMEDICINE & PHARMACOTHERAPY. 2024; 173: 116299-116299 Nº de citas: 2 [doi:10.1016/j.biopha.2024.116299]

  • Clemente-Bautista, S; Trocóniz, IF; Segarra-Cantón, O; Salvador-Marín, S; Parramón-Teixidó, CJ; Alvarez-Beltrán, M; López-Fernández, LA; Colom, H; Cabañas-Poy, MJ; Gorgas-Torner, MQ; Miarons, M.

    The Effect of Polymorphisms and Other Biomarkers on Infliximab Exposure in Paediatric Inflammatory Bowel Disease: Development of a Population Pharmacokinetic Model

    PEDIATRIC DRUGS. 2024; 26(3): 331-346 Nº de citas: 2 [doi:10.1007/s40272-024-00621-1]

  • Melero, R; Torroba-Sanz, B; Goicoechea, M; Sousa-Casasnovas, I; Barrio, J; García-Prieto, A; Rodriguez-Benitez, P; García-González, X; Sanjurjo-Sáez, M.

    Treatment with Rasburicase in Hospitalized Patients with Cardiorenal Syndrome: Old Treatment, New Scenario

    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2024; 25(6): [doi:10.3390/ijms25063329]

  • Morillo Verdugo R; Vicente Escrig E; Murillo Izquierdo M; Ibarra Barrueta O; Taberner Bonastre P; Fernández-Llamazares CM.

    Analisis de la evolución de la atención farmacéutica al paciente externo en los servicios de farmacia hospitalaria en España tras la puesta en marcha y desarrollo de la iniciativa MAPEX.

    Journal Of Healthcare Quality Research. 2024; 39(2): 65-79 Nº de citas: 2 [doi:10.1016/j.jhqr.2023.11.002]